Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. [electronic resource]
- International journal of clinical practice Sep 2004
- 867-76 p. digital
Publication Type: Journal Article; Review
1368-5031
10.1111/j.1742-1241.2004.00318.x doi
Contraindications Diabetes Mellitus, Type 2--drug therapy Drug Combinations Humans Hypoglycemic Agents--pharmacokinetics Insulin Resistance Metformin--pharmacokinetics Thiazoles--pharmacokinetics Treatment Outcome